There were 1,700 press releases posted in the last 24 hours and 358,678 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Myovant Sciences Submits Marketing Authorization Application to the European Medicines Agency for Relugolix Combination Tablet for the Treatment of Women with Uterine Fibroids

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image